Elevated serum cholesterol levels during pregnancy as predictors for postpartum hypercholesterolemia: A prospective cohort study
International Journal of Gynecology & Obstetrics · 2025-02 · 168 (2) · 800-811
DOI: 10.1002/ijgo.15922 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Gynecology & Obstetrics, online erschienen am 17.09.2024. Verfasst von Yandi Zhu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nutrition and Food Hygiene, School of Public Health, Capital Medical University, Beijing, China. Hauptthemen laut MEDLINE: Hypercholesterolemia, Postpartum Period, Cholesterol, Pregnancy Complications. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 25 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Objective
To identify the associations between gestational cholesterol levels and the risk of postpartum hypercholesterolemia, and to establish trimester‐specific reference values.
Methods
Serum lipids at gestational weeks 6–8, 16, 24, and 36, and 42 days postpartum were derived from 905 pregnant women of a prospective cohort. The major outcome was postpartum hypercholesterolemia. Logistic regression and restricted cubic splines were conducted to estimate the associations between cholesterol levels at specific gestational ages and postpartum hypercholesterolemia. Associations of the trend of changes in cholesterol levels during pregnancy with postpartum hypercholesterolemia were evaluated by linear mixed‐effect model and linear or logistic regression. Reference values were computed by the receiver operating characteristic curves.
Results
Serum concentrations of total cholesterol (TC), low‐density lipoprotein cholesterol (LDL‐C), high‐density lipoprotein cholesterol (HDL‐C), and the ratios of TC/HDL‐C and LDL‐C/HDL‐C all increased during pregnancy and decreased at 42 days postpartum. The elevated levels of TC and LDL‐C, decreased levels of HDL‐C in pregnancy, and their rapid change rates were positively associated with higher risks of postpartum hypercholesterolemia. The established reference values from the first to the third trimester were below 5.47, 6.35, and 7.22 mmol/L for TC; below 2.83, 3.82, and 4.21 mmol/L for LDL‐C; and more than 1.50, 1.55, and 1.50 mmol/L for HDL‐C, respectively.
Conclusion
Maternal cholesterol levels and their trend of change during pregnancy were predictors of postpartum hypercholesterolemia. Trimester‐specific reference values were established in a Chinese population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Nutrition and Food Hygiene, School of Public Health, Capital Medical University, Beijing, China.
- Department of Obstetrics, Fuxing Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Yandi Zhu, Huanling Yu
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Zhu, Y., Zhu, H., Dang, Q., Yang, Q., Zhao, X., Zhang, Y., Cai, X., Hu, Z., Wei, Y., Chen, Z., & Yu, H. (2025). Elevated serum cholesterol levels during pregnancy as predictors for postpartum hypercholesterolemia: A prospective cohort study. International Journal of Gynecology & Obstetrics, 168(2), 800-811. https://doi.org/10.1002/ijgo.15922
Vancouver
Zhu Y, Zhu H, Dang Q, Yang Q, Zhao X, Zhang Y, et al. Elevated serum cholesterol levels during pregnancy as predictors for postpartum hypercholesterolemia: A prospective cohort study. International Journal of Gynecology & Obstetrics. 2025;168(2):800-811. doi:10.1002/ijgo.15922
BibTeX
@article{Zhu2025,
author = {Zhu, Yandi and Zhu, Haiyan and Dang, Qinyu and Yang, Qian and Zhao, Xiaoyan and Zhang, Yadi and Cai, Xiaxia and Hu, Zhuo and Wei, Yuchen and Chen, Zhaoyang and Yu, Huanling},
title = {Elevated serum cholesterol levels during pregnancy as predictors for postpartum hypercholesterolemia: A prospective cohort study},
journal = {International Journal of Gynecology & Obstetrics},
year = {2025},
volume = {168},
number = {2},
pages = {800--811},
doi = {10.1002/ijgo.15922}
}
EUVIMED